Alfacalcidol soft capsule and preparation method thereof

Alfacalcidol soft capsule and preparation method thereof

The invention belongs to the technical field of medicament preparation, and particularly relates to an alfacalcidol soft capsule and a preparation method thereof. The alfacalcidol soft capsule consists of a soft capsule shell and a soft capsule content, the soft capsule shell is prepared from the fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHIM SUNG-BO, ZHENG LINHAI
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SHIM SUNG-BO
ZHENG LINHAI
description The invention belongs to the technical field of medicament preparation, and particularly relates to an alfacalcidol soft capsule and a preparation method thereof. The alfacalcidol soft capsule consists of a soft capsule shell and a soft capsule content, the soft capsule shell is prepared from the following raw materials: 60 to 100 parts of modified hydroxypropyl methylcellulose-starch matrix, 10 to 20 parts of citrate, 1 to 3 parts of nano zinc oxide and 100 to 150 parts of water; the soft capsule content is prepared from the following raw materials in parts by weight: 0.001 to 0.005 part of alfacalcidol, 500 to 800 parts of medium chain triglyceride, 1 to 5 parts of glyceryl monostearate, 0.5 to 2 parts of stabilizer and 5 to 10 parts of emulsifier. The alfacalcidol is prevented from being in contact with oxygen and water by adopting the modified hydroxypropyl methylcellulose and the starch shell. The drug is wrapped in glyceryl monostearate by using an ultrasonic emulsification technology, so that the chemi
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN118252813A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN118252813A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN118252813A3</originalsourceid><addsrcrecordid>eNrjZLBwzElLTE7MSc5Myc9RKM5PK1FITiwoLs1JVUjMS1EoKEotSCxKLMnMz1PITS3JyE9RKMlILUrNT-NhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaGFkamRhaGxo7GxKgBAByALns</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Alfacalcidol soft capsule and preparation method thereof</title><source>esp@cenet</source><creator>SHIM SUNG-BO ; ZHENG LINHAI</creator><creatorcontrib>SHIM SUNG-BO ; ZHENG LINHAI</creatorcontrib><description>The invention belongs to the technical field of medicament preparation, and particularly relates to an alfacalcidol soft capsule and a preparation method thereof. The alfacalcidol soft capsule consists of a soft capsule shell and a soft capsule content, the soft capsule shell is prepared from the following raw materials: 60 to 100 parts of modified hydroxypropyl methylcellulose-starch matrix, 10 to 20 parts of citrate, 1 to 3 parts of nano zinc oxide and 100 to 150 parts of water; the soft capsule content is prepared from the following raw materials in parts by weight: 0.001 to 0.005 part of alfacalcidol, 500 to 800 parts of medium chain triglyceride, 1 to 5 parts of glyceryl monostearate, 0.5 to 2 parts of stabilizer and 5 to 10 parts of emulsifier. The alfacalcidol is prevented from being in contact with oxygen and water by adopting the modified hydroxypropyl methylcellulose and the starch shell. The drug is wrapped in glyceryl monostearate by using an ultrasonic emulsification technology, so that the chemi</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240628&amp;DB=EPODOC&amp;CC=CN&amp;NR=118252813A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240628&amp;DB=EPODOC&amp;CC=CN&amp;NR=118252813A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHIM SUNG-BO</creatorcontrib><creatorcontrib>ZHENG LINHAI</creatorcontrib><title>Alfacalcidol soft capsule and preparation method thereof</title><description>The invention belongs to the technical field of medicament preparation, and particularly relates to an alfacalcidol soft capsule and a preparation method thereof. The alfacalcidol soft capsule consists of a soft capsule shell and a soft capsule content, the soft capsule shell is prepared from the following raw materials: 60 to 100 parts of modified hydroxypropyl methylcellulose-starch matrix, 10 to 20 parts of citrate, 1 to 3 parts of nano zinc oxide and 100 to 150 parts of water; the soft capsule content is prepared from the following raw materials in parts by weight: 0.001 to 0.005 part of alfacalcidol, 500 to 800 parts of medium chain triglyceride, 1 to 5 parts of glyceryl monostearate, 0.5 to 2 parts of stabilizer and 5 to 10 parts of emulsifier. The alfacalcidol is prevented from being in contact with oxygen and water by adopting the modified hydroxypropyl methylcellulose and the starch shell. The drug is wrapped in glyceryl monostearate by using an ultrasonic emulsification technology, so that the chemi</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBwzElLTE7MSc5Myc9RKM5PK1FITiwoLs1JVUjMS1EoKEotSCxKLMnMz1PITS3JyE9RKMlILUrNT-NhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaGFkamRhaGxo7GxKgBAByALns</recordid><startdate>20240628</startdate><enddate>20240628</enddate><creator>SHIM SUNG-BO</creator><creator>ZHENG LINHAI</creator><scope>EVB</scope></search><sort><creationdate>20240628</creationdate><title>Alfacalcidol soft capsule and preparation method thereof</title><author>SHIM SUNG-BO ; ZHENG LINHAI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN118252813A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SHIM SUNG-BO</creatorcontrib><creatorcontrib>ZHENG LINHAI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHIM SUNG-BO</au><au>ZHENG LINHAI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Alfacalcidol soft capsule and preparation method thereof</title><date>2024-06-28</date><risdate>2024</risdate><abstract>The invention belongs to the technical field of medicament preparation, and particularly relates to an alfacalcidol soft capsule and a preparation method thereof. The alfacalcidol soft capsule consists of a soft capsule shell and a soft capsule content, the soft capsule shell is prepared from the following raw materials: 60 to 100 parts of modified hydroxypropyl methylcellulose-starch matrix, 10 to 20 parts of citrate, 1 to 3 parts of nano zinc oxide and 100 to 150 parts of water; the soft capsule content is prepared from the following raw materials in parts by weight: 0.001 to 0.005 part of alfacalcidol, 500 to 800 parts of medium chain triglyceride, 1 to 5 parts of glyceryl monostearate, 0.5 to 2 parts of stabilizer and 5 to 10 parts of emulsifier. The alfacalcidol is prevented from being in contact with oxygen and water by adopting the modified hydroxypropyl methylcellulose and the starch shell. The drug is wrapped in glyceryl monostearate by using an ultrasonic emulsification technology, so that the chemi</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN118252813A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Alfacalcidol soft capsule and preparation method thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A24%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHIM%20SUNG-BO&rft.date=2024-06-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN118252813A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true